Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography Abstract Assessment of attenuation (measured in Hounsfield units, HU) of human coronary plaques was performed using multislice computed tomography (MSCT) in an ex vivo model. In three ex vivo specimens of left coronary arteries in oil, MSCT was performed after intracoronary injection of four solutions of contrast material (400 mgI/ml iomeprol). The four solutions were diluted as follows: 1/∞, 1/200, 1/80, and 1/20. All scans were performed with the following parameters: slices/collimation 16/0.75 mm, rotation time 375 ms. Each specimen was scored for the presence of atherosclerotic plaques. In each plaque the attenuation was measured in four regions of interest for lumen, plaque (non-calcified thickening of the vessel wall), calcium, and surrounding (oil surrounding the vessel). The results were compared with a one-way analysis of variance test and were correlated with Pearson's test. There were no significant differences in the attenuation of calcium and oil in the four solutions. The mean attenuation in the four solutions for lumen (35±10, 91±7, 246±18, 511±89 HU) and plaque (22±22, 50±26, 107±36, 152±67 HU) was significantly different between each decreasing dilution (p<0.001). The mean attenuation of lumen and plaque of coronary plaques showed high correlation, while the values were significantly different (r=0.73; p<0.001). Intracoronary attenuation modifies significantly the attenuation of plaques assessed with MSCT.
Introduction
Several studies reported that atherosclerotic plaque composition and morphology are important predictors of plaque stability and clinical behaviour when compared with the degree of vessel stenosis [1] [2] [3] .
Quantitative and qualitative information (e.g. lumen diameter, wall thickness, and morphology) can be obtained using intracoronary ultrasound (ICUS), which has been approved by Food and Drug Administration as the standard for the in vivo evaluation of coronary plaques [4] [5] [6] . This technique cannot be used for routine evaluation of plaque characteristics because of its invasiveness and cost.
Several non-invasive techniques have been tested for the visualisation and characterisation of coronary plaques. Preliminary reports using magnetic resonance imaging have reported the ability to detect and characterise the lipid pool in atherosclerotic plaques at the level of the carotid arteries [7] , and in the coronary arteries [8] [9] [10] .
Multislice computed tomography (MSCT) coronary angiography has showed good potential in the detection, quantification, and characterisation of coronary artery plaques [11] [12] [13] [14] [15] [16] . Nevertheless, several aspects concerning the methodology for the assessment of coronary plaques with MSCT coronary angiography remain unexplored.
With this study we address the issue of the variability of coronary plaque attenuation as measured with MSCT in an ex vivo model with varying intracoronary attenuation.
Materials and methods

Specimens
Three left coronary arteries were dissected during autopsy. The dissected arteries were sampled 1 cm proximal to the bifurcation of the LCx and covered a length of 4 cm. For orientation the anterior side of the arteries was inked in black and the left side of the artery in green. Two patients (both males, with ages of 78 and 63 years) died of noncardiovascular diseases. One patient (female, with an age of 73 years) died of ischaemic heart disease. The study was approved by the Medical Committee of the Middelheim Hospital.
The specimens were prepared and scanned separately. Each specimen was prepared with two sheaths. The sheaths were introduced and fixed at the proximal end (in the left main coronary artery) and at the distal end (in the anterior descending artery) of the specimens. The left circumflex was, previously, closed at its end with a wire.
Contrast material
Four saline solutions with decreasing dilution of contrast material (400 mgI/ml iomeprol, Bracco, Italy) were used: 1/∞, 1/200, 1/80, and 1/20. The attenuation values (Hounsfield units, HU) of the four solutions obtained in a 10-ml syringe after dilution were 3.2±4.5 HU (1/∞; defined as saline; no contrast material was diluted), 144.7± 8.6 HU (1/200; defined as low), 298.4±3.4 HU (1/80; defined as medium), and 588.0±6.0 HU (1/20; defined as high).
Experimental settings
The experimental settings included a box that was filled with vegetable oil. Prior to positioning the specimen in the oil, saline was instilled through the sheaths to wash out as much as possible. The specimens were put into oil as a means of simulating the epicardial fat. Once the specimen had sunk into the oil, the solution was injected through the sheath using a 10-ml syringe from the sheath positioned at the proximal end of the specimen. The injection was finished when the solution was observed leaking out of the specimen. The leaking solution was removed from the specimen using an empty syringe. The specimen was not mobilised between the scans.
Scan parameters
A MSCT scan (Sensation 16, Siemens, Germany) was performed after intracoronary injection with increasing concentration of contrast material. After each scan the coronary arteries were washed out with saline before the injection of the following solution and the leaking solution was removed from the specimen using an empty syringe.
All scans were performed with the following parameters: slices/collimation 16/0.75 mm, rotation time 375 ms, feed/ rotation 3.0 mm (pitch 0.25), 120 kV, 400 mAs, effective slice thickness 1 mm, reconstruction increment 0.5 mm, field of view (FOV) 100 mm, convolution filter medium smooth (B30f). The scan geometry was based on a retrospective ECG gated protocol (the same used for in vivo MSCT coronary angiography). This protocol is based on a low pitch that allows a retrospective reconstruction of multiple phases within the cardiac cycle. In this case, a demo ECG was switched on and the scan was performed as if the heart rate was 71 beats per minute. The reconstruction algorithm uses 180°of rotation, bringing the effective temporal resolution down to 187 ms.
Data preparation
In order to analyse the specimen with the same settings an experienced operator loaded the datasets into a dedicated workstation (Leonardo, Siemens, Germany) and performed a stack of orthogonal views in each solution for all the specimens with the following parameters: slice thickness 1 mm, increment 0.5 mm, FOV 50 mm.
Data collection
One observer performed all the measurements. Each specimen was evaluated for the presence of coronary atherosclerotic plaques. A coronary atherosclerotic plaque was defined as a thickening of the coronary wall clearly distinguished from the surrounding hypo-attenuating oil and from the lumen after injection of the solution with the lowest dilution of contrast material (e.g. high). Plaques where targeted regardless of their size. The operator loaded the four datasets for each dilution of the same specimen onto a workstation screen divided 2×2, scrolling the datasets in parallel with standard window settings (window width 700 HU; window centre 140 HU). Once a plaque had been detected in the four solutions, the operator drew four regions of interest (ROIs) for contrast material in the lumen of the vessel (defined as lumen), the soft tissue of the coronary plaque (defined as plaque), the calcification within the coronary artery wall (defined as calcium), and the oil immediately surrounding the plaque (defined as surrounding). These four ROIs were defined as structures. The first drawing of the ROI was performed in the dataset with the lowest dilution of contrast material because the lumen was easier to identify. The ROIs were drawn as large as possible but avoiding the borders of each structure in order to limit the effect of interpolation and partial volume on the measurement. Once the four ROIs of the structures had been drawn the operator could copy and paste the ROIs into the other stacks of images corresponding to different solutions. Therefore, the position of the ROIs was mirrored in each orthogonal slice with a plaque for each solution. The mean attenuation in each ROI was collected.
Statistical analysis
The values of attenuation are presented as means and standard deviations. Statistical evaluation was performed with dedicated software (SPSS 10.1, SPSS, Chicago, IL, USA). The attenuation measurements in each solution within the structure and clustered per structure were compared with a one-way analysis of variance test and were correlated with Pearson's test. For each structure (e.g. lumen, plaque, calcium, and surrounding), the attenuation values obtained in the four solutions were plotted in order to obtain a slope. The mean slope of each structure was tested for significant differences. For all comparisons tested, p<0.05 was considered significant.
Results
Overall 109 levels (1-mm apart from each other) containing plaque were measured in the three coronary specimens. At each level four solutions were available (436 slices) and in each slice four ROIs were sampled (1,744 samples). The results are summarised in Table 1 . The mean attenuation obtained for all samples was 223± 187 HU for the lumen, 86±71 HU for the plaque, 641± 534 HU for the calcium, and −124±11 HU for the surrounding. The values were all significantly different (p<0.05).
The mean slopes obtained for all the four structures were: 153±31 for the lumen, 46±26 for the plaque, 8±31 for the calcium, and 1±6 for the surrounding. Values were all significantly different between the structures (p<0.05).
The mean attenuations in the four solutions for the four structures are displayed in Table 1 and Fig. 1 . The attenuation values of the lumen and of the plaques were significantly different in each structure (p<0.01). The attenuation values of the calcium and of the surrounding were not significantly different in each structure (p>0.05).
After clustering the paired attenuation values obtained for the four structures in all the four solutions the correlation between the structures was good (r=0.733) only between the attenuation values of the lumen and the plaque ( Table 2 , Fig. 2 ).
Discussion
Several studies reported the ability of MSCT to visualise coronary atherosclerotic plaque [12, 14, 15, [17] [18] [19] [20] .
An in vivo study by Kopp et al. [11] compared MSCT and ICUS in the characterisation of coronary plaques. The plaques were divided for the attenuation values into soft (6±28 and −5±25 HU; two plaques), intermediate (83±17 and 51±19 HU; two plaques) and calcified (489±372 and 423±111 HU; two plaques). The MSCT criteria based on attenuation values showed excellent correspondence with the ICUS criteria.
In an in vivo study, Schroeder et al. [12] analysed the composition of 34 plaques by comparing MSCT and ICUS. They found that plaque echogenicity as determined by ICUS corresponds well to plaque attenuation as measured by MSCT.
Leber et al. [16] in an in vivo study showed that lesion echogenicity correlates well with MSCT attenuation measurements in coronary plaques. The attenuation values for hypoechoic, hyperechoic, and calcified plaques were 49, 91, and 391 HU, respectively. The MSCT attenuation values reflect the predominant plaque composition (e.g. a plaque with a large lipid core with a low echogenicity on ICUS might be identified on the basis of a low attenuation value).
Becker et al. [13] investigated 11 human cadaver heart specimens and compared the atherosclerotic lesions detected by MSCT (n=40) with the histopathological macroscopic characterisation according to American Heart Association criteria. They concluded that MSCT is a promising tool for the characterisation of atherosclerotic coronary lesions.
From the literature cited previously, it appears that MSCT can provide data and characterise coronary artery plaques, on the basis of the attenuation values.
In a phantom study, Schroeder et al. [17] measured the attenuation of two plaques made of rubber material after injection within a tube (simulating a coronary artery) of contrast material of three decreasing concentrations: 1:30 (336 HU), 1:40 (280 HU), and 1:50 (258 HU). The increased attenuation of the contrast material determined an increase in the measured attenuation of the plaque. Because of this observation we studied the influence of intravascular attenuation on the assessment of coronary plaques with MSCT.
In our experimental study we showed that lumen attenuation measured by MSCT significantly affects the measured plaque attenuation (Fig. 3) . The higher the lumen attenuation, the higher the plaque attenuation. Calcium attenuation and surrounding fat attenuation are, in contrast, not significantly affected. On the basis of this finding, it is difficult to identify absolute ranges of attenuation that relate to the specific plaque characteristics.
Several factors and parameters affect the accuracy of the attenuation measurement. Partial volume and interpolation modify the profiles of attenuation in the range of the soft tissues. This is particularly important when there are calcifications in the plaque and contrast material in the lumen in contiguity with the ROI; therefore, absolute plaque attenuation values determined in the various studies are not comparable.
Our observation has a potential impact on the approach to plaque measurements with MSCT. In fact, since the attenuation within the lumen affects the attenuation within the plaque, further studies should probably focus on the relationship between these two variables. On the basis of our results the relationship appears to be close to linear. Thus, a coefficient could be introduced when plaque measurements are performed in order to compare the different studies.
One of the most important features of the vulnerable plaque is the lipid core. The usual location of the lipid core within the atherosclerotic plaque is just below the thin cap. This means that it is also very close to the attenuation of the lumen as displayed in MSCT. In this area the attenuation measurements will be affected the most by intravascular attenuation.
There are several limitations in our study. The first one is due to the lack of motion in the specimens. The artefacts derived from the heartbeat were not present and/or reproduced. The second limitation is related to the low number of specimens. Nevertheless, the high sampling rate using cross-sectional views of the vessels balanced this. The third limitation is that an excised coronary specimen does not necessarily represent the reality of a coronary vessel. The third limitation is inherent to the lack of a histopathological correlation. Yet, the aim of our study was not to correlate histopathology with MSCT, but to assess the influence of intracoronary attenuation on overall plaque attenuation measurements. The fourth limitation is that we cannot assume that what was described in our study could be directly transferred to different multislice techniques. The fifth limitation is that we did not investigate the influence of convolution kernels on plaque attenuation. Finally, a moving coronary phantom would provide more realistic information regarding plaque attenuation.
In addition it should be taken into account that the introduction of 64-slice CT systems will probably require an additional optimisation of this methodology.
In conclusion, intravascular attenuation modifies significantly the attenuation of the coronary atherosclerotic plaques assessed with MSCT. Therefore, the characterisation of the plaque on the basis of absolute attenuation values should be reported with caution. When plaque attenuation is measured, intraluminal attenuation should also be reported. Probably, a calibration factor will be introduced in the future to address this issue. Fig. 3 Example of plaque in the four solutions. The scheme in the upper left corner shows the configuration of the plaque in an orthogonal cut performed with multislice computed tomography. The four solutions producing a progressive increase in lumen attenuation are displayed from left to right in the upper part of the figure. Below the relevant attenuations are displayed for every structure.
